FORT LAUDERDALE, Fla., Dec. 19, 2016 /PRNewswire/ -- Attorney Advertising -- the law firm of Salpeter Gitkin, LLP is informing investors and shareholders of Allergan plc ("Allergan" or the "Company") (NYSE: AGN) of various securities class actions that have been filed on behalf of investors of the Company. The lawsuits are on behalf of investors who purchased or otherwise acquired Allergan securities between February 25, 2014 and November 2, 2016. It is alleged that the Company made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects.
Although Salpeter Gitkin, LLP is currently not involved in the lawsuits, it is endeavoring to inform investors and provide counsel to those seeking information about the claims. If you are an investor and would like to find out more information, please contact Salpeter Gitkin, LLP (Attn: James Gitkin) at 800-675-4128 or firstname.lastname@example.org or shareholders can complete the contact page at http://www.salpetergitkin.com/Contact.shtml.
Allergan, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. The Company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015 after acquiring Allergan Inc. The Company's common stock has traded under the ticker symbol "AGN" since June 15, 2015. Prior to June 15, 2015, the common stock of Actavis plc traded on the NYSE under the ticker symbol "ACT".
Salpeter Gitkin, LLP is a civil litigation and transactional law firm handling cases throughout the United States. Its principal areas of practice include shareholder and consumer class actions, serious personal injury, complex commercial ligation, and real estate litigation and transactions. The firm is currently investigating and litigating various shareholder claims against major corporations. More information on the firm and its lawyers can be found at www.salpetergitkin.com.
Salpeter Gitkin, LLP
Attn: James P. Gitkin, Esq.
1 E. Broward Boulevard
Fort Lauderdale, FL 33301
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/salpeter-gitkin-llp-informing-investors-of-allergan-plc-of-securities-class-action-lawsuits-300381146.html
SOURCE Salpeter Gitkin, LLP